adrenaclick Drug Patent Profile

✉ Email this page to a colleague

When do Adrenaclick patents expire, and what generic alternatives are available?

Adrenaclick is a drug marketed by Impax and is included in one NDA.

The generic ingredient in ADRENACLICK is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Adrenaclick

A generic version of adrenaclick was approved as epinephrine by BPI LABS on July 29^th, 2014.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for adrenaclick?
What are the global sales for adrenaclick?
What is Average Wholesale Price for adrenaclick?

Summary for adrenaclick

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	2
Patent Applications:	4,299
Drug Prices:	Drug price information for adrenaclick
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for adrenaclick
DailyMed Link:	adrenaclick at DailyMed

Drug patent expirations by year for adrenaclick

Recent Clinical Trials for adrenaclick

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Louisville	Phase 4
Arthroplasty Foundation, Inc.	Phase 4
NYU Langone Health	N/A

See all adrenaclick clinical trials

US Patents and Regulatory Information for adrenaclick

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Impax	ADRENACLICK	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020800-003	Nov 25, 2009	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Impax	ADRENACLICK	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020800-004	Nov 25, 2009	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for adrenaclick

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Impax	ADRENACLICK	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020800-003	Nov 25, 2009	⤷ Sign Up	⤷ Sign Up
Impax	ADRENACLICK	epinephrine	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020800-004	Nov 25, 2009	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for adrenaclick

See the table below for patents covering adrenaclick around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	7046294		⤷ Sign Up
World Intellectual Property Organization (WIPO)	2006062788		⤷ Sign Up
Russian Federation	2008103666	СПОСОБ ЛЕЧЕНИЯ ОСТРОЙ АЛЛЕРГИИ И УСТРОЙСТВО ДЛЯ ДОСТАВКИ ЛЕКАРСТВЕННОГО СРЕДСТВА	⤷ Sign Up
Japan	2008522659		⤷ Sign Up
Poland	311759		⤷ Sign Up
World Intellectual Property Organization (WIPO)	2009150078		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for adrenaclick

Recent Clinical Trials for adrenaclick

Make Better Decisions: Try a trial or see plans & pricing